Enisamium iodide

Enisamium iodide

Chemical formula
Clinical data
Trade names	Amizon
Other names	Carbabenzpiride 4-(N-Benzyl) aminocarbonyl-1-methylpyridinium iodide N-Methyl-4-benzylurebamidopyridinium iodide
ATC code	J05AX17 (WHO)
Pharmacokinetic data
Metabolism	liver
Excretion	kidneys
Identifiers
IUPAC name N-benzyl-1-methylpyridin-1-ium-4-carboxamide iodide
CAS Number	201349-37-3
PubChem CID	10089466
ChemSpider	8265003
UNII	G22FG6Q00B
KEGG	D11249
ChEMBL	ChEMBL1716983
CompTox Dashboard (EPA)	DTXSID00173960
Chemical and physical data
Formula	C14H15IN2O
Molar mass	354.191 g·mol−1
3D model (JSmol)	Interactive image
SMILES C[N+]1=CC=C(C=C1)C(=O)NCC2=CC=CC=C2.[I-]
InChI InChI=1S/C14H14N2O.HI/c1-16-9-7-13(8-10-16)14(17)15-11-12-5-3-2-4-6-12;/h2-10H,11H2,1H3;1H Key:ILSOAHPXYZRFBA-UHFFFAOYSA-N

Enisamium iodide is a derivative of isonicotinic acid. Based on its systematic chemical name of N-benzyl-1-methylpyridin-1-ium-4-carboxamide iodide, the shortened name carbabenzpiride is sometimes used. Enisamium iodide is a registered antiviral drug sold in Ukraine, Kazakhstan, Mongolia, Belarus, and other Eastern European countries under the trade names Amizon, Amizon Max, Amizonchik.^[1]

In 2019, the World Health Organization assigned enisamium iodide ATC code – J05AX17 (Antivirals for systemic use of direct action) and included it in the ATC / DDD index.^[2]